ClinVar Miner

Submissions for variant NM_000551.4(VHL):c.291_302del (p.Tyr98_Leu101del)

dbSNP: rs1575922296
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000812797 SCV000953122 pathogenic Chuvash polycythemia; Von Hippel-Lindau syndrome 2019-04-29 criteria provided, single submitter clinical testing This variant has been observed to be de novo in an individual with clinical features of von Hippel-Lindau syndrome (Invitae). This variant, c.291_302delCTACCCAACGCT, results in the deletion of 4 amino acids of the VHL protein (p.Tyr98_Leu101del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (ExAC no frequency). Variants that disrupt the p.Tyr98 amino acid residue in VHL have been observed in affected individuals (PMID: 7759077, 7728151, 10408776, 21204227, 19763184, 19336503, 11483638). This suggests that it is a clinically significant residue, and that other variants that disrupt this residue are likely to be causative of disease. For these reasons, this variant has been classified as Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.